By Thomas Insel on February 05, 2013
Dr. Insel talks about how NIMH’s RAISE study is exploring an integrated, multi-component approach to health care for schizophrenia.
Continue reading “Network Solutions”…
By Thomas Insel on November 15, 2012
Dr. Insel introduces an innovative approach that one group is taking to speed up the dissemination of research results into clinical practice.
Continue reading “From Practice to Research”…
By Thomas Insel on August 06, 2012
Dr. Insel describes a new behavioral treatment for a neurologically based disorder that has traditionally been difficult to treat.
Continue reading “A Promising Behavioral Treatment for Tourette Syndrome”…
By Thomas Insel on June 12, 2012
Dr. Insel discusses the crisis of medication development for mental disorders.
Continue reading “Experimental Medicine”…
By Thomas Insel on April 26, 2012
Presentations at a recent meeting in San Diego showed how new technologies are being used to change the culture of science, empowering patients, and fueling innovative research approaches.
Continue reading “Citizen Science”…
By Thomas Insel on April 20, 2012
While fewer medical students are choosing psychiatry in the U.K., in the U.S. psychiatry is attracting increasing numbers of elite MD-PhD students who want to do research. These young scientists are committed to developing a new scientific basis for clinical care.
Continue reading “The Future of Psychiatry (= Clinical Neuroscience)”…
By Thomas Insel on January 05, 2012
Dr. Insel discusses opportunities for treatment development.
Continue reading “Treatment Development: Where do we go from here?”…
By Thomas Insel on December 23, 2011
Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.
Continue reading “NIMH’s Top 10 Research Advances of 2011”…
By Thomas Insel on December 22, 2011
Dr. Insel discusses opportunities for treatment development.
Continue reading “Treatment Development: Where do we go from here?”…
By Thomas Insel on December 14, 2011
Dr. Insel discusses the state of psychiatric research and development (R&D) in the public and private sectors
Continue reading “Treatment Development: The Past 50 Years”…
By Thomas Insel on December 06, 2011
Dr. Insel discusses the complicated nature of research on the efficacy antidepressants.
Continue reading “Antidepressants: A complicated picture”…
By Thomas Insel on November 18, 2011
Dr. Insel reflects on an exciting neuroscience conference where an increasing interest in neuropsychiatric disorders was evident.
Continue reading “Neuroscience Advances Showcased in Washington”…
By Thomas Insel on May 20, 2011
Dr. Insel provides a vision for future clinical research.
Continue reading “Making the Most of our Interventions Research”…
By Thomas Insel on August 30, 2010
Dr. Insel discusses the evolution of clinical research and changing priorities in clinical research funding.
Continue reading “Taking Clinical Research to the Next Level”…
By Thomas Insel on August 13, 2010
Increasing evidence linking strep infection to OCD in children suggests that microbiomics may prove an important research area for understanding and treating mental disorders.
Continue reading “Microbes and Mental Illness”…
By Thomas Insel on July 30, 2010
Dr. insel discusses two important initiatives that will have a broad impact on NIMH’s clinical research portfolio.
Continue reading “Three Principles for Clinical Research”…
The National Institute of Mental Health (NIMH) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services.
NIH…Turning Discovery Into Health®
This page last reviewed: November 03, 2010.
